Hubert Fleury

864 citations

13 papers · 390 indexed · h-index 11

Impact in

Oncology
- PARP inhibition in cancer therapy
- Cancer Cells and Metastasis
Aging

Papers in ⓘ

Molecular Biology 9
- DNA Repair Mechanisms 5
- CRISPR and Genetic Engineering 3
Oncology 8
- PARP inhibition in cancer therapy 6
- Cancer Cells and Metastasis 2

Co-authors: Anne‐Marie Mes‐Masson (10 shared papers)Eurı́dice Carmona (7 shared papers)Diane Provencher (7 shared papers)Laudine Communal (2 shared papers)Sophie Gilbert (2 shared papers)Nicolas Malaquin (1 shared paper)Marc‐Alexandre Olivier (1 shared paper)Aurélie Martinez (1 shared paper)
Journals: Oncotarget (2 papers)Genes & Cancer (1 paper)Scientific Reports (1 paper)Nature Communications (1 paper)BMC Medicine (1 paper)
Partner nations: Canada United Kingdom New Zealand

In The Last Decade

Hubert Fleury

13 papers receiving 389 citations

Peers

Countries citing papers authored by Hubert Fleury

Since Specialization

Citations

This map shows the geographic impact of Hubert Fleury's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hubert Fleury with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hubert Fleury more than expected).

Fields of papers citing papers by Hubert Fleury

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hubert Fleury. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hubert Fleury. The network helps show where Hubert Fleury may publish in the future.

Co-authors

The 25 scholars most cited alongside Hubert Fleury, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Hubert Fleury Line = papers co-authored together Hubert Fleury links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

13 of 13 papers shown

#	Work
1	Exploiting interconnected synthetic lethal interactions between PARP inhibition and cancer cell reversible senescence Nature Communications ·Hubert Fleury, Nicolas Malaquin, Véronique Tu, Sophie Gilbert, Aurélie Martinez, Marc‐Alexandre Olivier, Skye Alexandre Sauriol, Laudine Communal, Kim Leclerc-Desaulniers, Eurı́dice Carmona, Diane Provencher, Anne‐Marie Mes‐Masson, Françis Rodier	2019	162
2	Roles for APRIN (PDS5B) in homologous recombination and in ovarian cancer prediction Nucleic Acids Research ·Anthony M. Couturier, Hubert Fleury, Anne‐Marie Patenaude, Victoria L. Bentley, Amélie Rodrigue, Yan Coulombe, Niraj Joshi, Joris Pauty, Jason N. Berman, Graham Dellaire, Javier M. Di Noia, Anne‐Marie Mes‐Masson, Jean‐Yves Masson	2016	39
3	Carboplatin response in preclinical models for ovarian cancer: comparison of 2D monolayers, spheroids, ex vivo tumors and in vivo models Scientific Reports ·Melica Nourmoussavi Brodeur, Kayla Simeone, Kim Leclerc-Deslauniers, Hubert Fleury, Eurı́dice Carmona, Diane Provencher, Anne‐Marie Mes‐Masson	2021	29
4	Novel high-grade serous epithelial ovarian cancer cell lines that reflect the molecular diversity of both the sporadic and hereditary disease Genes & Cancer ·Hubert Fleury, Laudine Communal, Eurı́dice Carmona, Lise Portelance, Suzanna L. Arcand, Kurosh Rahimi, Patricia N. Tonin, Diane Provencher, Anne‐Marie Mes‐Masson	2015	26
5	The APE2 nuclease is essential for DNA double-strand break repair by microhomology-mediated end joining Molecular Cell ·Hubert Fleury, Myles K. MacEachern, Clara M. Stiefel, Roopesh Anand, Colin Sempeck, Benjamin Nebenfuehr, Kelper Maurer-Alcalá, Kerri A. Ball, Bruce Proctor, Ondrej Beláň, Erin Taylor, Raquel Ortega, Benjamin Dodd, Laila Weatherly, Djelika Dansoko, Justin Leung, Simon J. Boulton, Nausica Arnoult	2023	24
6	Cumulative defects in DNA repair pathways drive the PARP inhibitor response in high-grade serous epithelial ovarian cancer cell lines Oncotarget ·Hubert Fleury, Eurı́dice Carmona, Vincent Morin, Liliane Meunier, Jean‐Yves Masson, Patricia N. Tonin, Diane Provencher, Anne‐Marie Mes‐Masson	2016	23
7	Carboplatin sensitivity in epithelial ovarian cancer cell lines: The impact of model systems PLoS ONE ·Bishnubrata Patra, Muhammad Abdul Lateef, Melica Nourmoussavi Brodeur, Hubert Fleury, Eurı́dice Carmona, Benjamin Péant, Diane Provencher, Anne‐Marie Mes‐Masson, Thomas Gervais	2020	20
8	Chemotherapy reduces PARP1 in cancers of the ovary: implications for future clinical trials involving PARP inhibitors BMC Medicine ·Maud Marques, Marie‐Claude Beauchamp, Hubert Fleury, Ido Laskov, Qiang Sun, Manuela Pelmus, Diane Provencher, Anne‐Marie Mes‐Masson, Walter H. Gotlieb, Michael Witcher	2015	16
9	Pre-activation of autophagy impacts response to olaparib in prostate cancer cells Communications Biology ·M Cahuzac, Patricia Langlois, Benjamin Péant, Hubert Fleury, Anne‐Marie Mes‐Masson, Fred Saad	2022	14
10	Proximal and distal regulation of the HYAL1 gene cluster by the estrogen receptor α in breast cancer cells Oncotarget ·Lydia Edjekouane, Samira Benhadjeba, Maïka Jangal, Hubert Fleury, Nicolas Gévry, Eurı́dice Carmona, André Tremblay	2016	12
11	The CD73 immune checkpoint promotes tumor cell metabolic fitness eLife ·David Allard, Isabelle Cousineau, H. Eric, Bertrand Allard, Yacine Barèche, Hubert Fleury, John Stagg	2023	11
12	NR1D1 regulation by Ran GTPase via miR4472 identifies an essential vulnerability linked to aneuploidy in ovarian cancer Oncogene ·Zied Boudhraa, Kossay Zaoui, Hubert Fleury, M Cahuzac, Sophie Gilbert, Guergana Tchakarska, Jennifer Kendall‐Dupont, Eurı́dice Carmona, Diane Provencher, Anne‐Marie Mes‐Masson	2021	9
13	Long-term fluorescence hyperspectral imaging of on-chip treated co-culture tumour spheroids to follow clonal evolution Integrative Biology ·Amélie St‐Georges‐Robillard, M Cahuzac, Benjamin Péant, Hubert Fleury, Muhammad Abdul Lateef, Alexis Ricard, Skye Alexandre Sauriol, Frédéric Leblond, Anne‐Marie Mes‐Masson, Thomas Gervais	2019	5

About Hubert Fleury

Hubert Fleury is a scholar working on Molecular Biology, Oncology, Biomedical Engineering, Genetics and Immunology, having authored 13 papers that have together received 390 indexed citations. Recurring topics across this work include PARP inhibition in cancer therapy (6 papers), DNA Repair Mechanisms (5 papers), CRISPR and Genetic Engineering (3 papers), Cancer Cells and Metastasis (2 papers), Microfluidic and Bio-sensing Technologies (2 papers), Ovarian cancer diagnosis and treatment (2 papers), 3D Printing in Biomedical Research (2 papers) and Telomeres, Telomerase, and Senescence (1 paper). The work is most often cited by research in Oncology (179 citations), Aging (8 citations), Physiology (99 citations), Physiology (17 citations) and Immunology (69 citations). Hubert Fleury has collaborated with scholars based in Canada, United Kingdom and New Zealand. Frequent co-authors include Anne‐Marie Mes‐Masson, Eurı́dice Carmona, Diane Provencher, Laudine Communal, Sophie Gilbert, Nicolas Malaquin, Marc‐Alexandre Olivier, Aurélie Martinez, Françis Rodier and Jean‐Yves Masson. Their work appears in journals such as Oncotarget, Genes & Cancer, Scientific Reports, Nature Communications and BMC Medicine.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact